P2.16A.01 Actionable Alterations Identification in NSCLC by Comprehensive Genomic Profiling for Clinical Trial Enrollment: EPROPA

Authors :: Vallone, S.
Passiglia, F.
Listi, A.
Bironzo, P.
Merlini, A.
Benso, F.
Napoli, F.
Barbu, F.A.
Zambelli, V.
Tabbò, F.
Reale, M.L.
Sini, C.
Roca, E.
Taveggia, P.A.
Simionato, F.
Buffoni, L.
Mazilu, L.
Barbieri, V.
Pignataro, D.
Araujo, A.
Paz-Ares, L.
Félip, E.
Secen, N.
Comanescu, A.
Mati Ramizi, K.
Bettini, A.C.
Scotti, V.
Linardou, H.
Mohorcic, K.
Meoni, G.
Volante, M.
Scagliotti, G.
Malapelle, U.
Righi, L.
Novello, S.
Source :: Journal of Thoracic Oncology; October 2024, Vol. 19 Issue: 10, Number 10 Supplement 1 pS282-S282, 1p
Publication Year :: 2024

Full Text Access

Tools